June 24, 2026 · Form 4 insider transaction
POST LEONARD E sold 5,000 shares of CG Oncology, Inc. at $70.00 per share, a transaction worth $350.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026.